3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neoplasms
19
Breast Neoplasms
15
Prostatic Neoplasms
14
Colorectal Neoplasms
14
Hematopoietic and Lymphatic System Neoplasm
13
Lung Neoplasms
11
Ovarian Neoplasms
5
Multiple Myeloma
5
Hematologic Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Malignant Solid Neoplasm
4
Hematopoietic and Lymphoid System Neoplasm
4
Depression
4
Uterine Cervical Neoplasms
3
Neoplasm Metastasis
3
Lymphoma
3
Laryngeal Neoplasms
3
Head and Neck Neoplasms
3
Anxiety Disorders
3
Anatomic Stage I Breast Cancer AJCC v8
3
Advanced Malignant Solid Neoplasm
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Cancer, Papillary
2
Oropharyngeal Neoplasms
2
Mouth Neoplasms
2
Motor Activity
2
Melanoma
2
Malignant Female Reproductive System Neoplasm
2
Leukemia, Myeloid, Acute
2
Interventions
Cyclophosphamide
101
Etoposide
60
Carboplatin
55
Vincristine
51
Filgrastim
49
Topotecan
44
Temozolomide
44
Melphalan
44
Isotretinoin
44
Doxorubicin
44
Irinotecan
42
Cisplatin
35
Peripheral Blood Stem Cell Transplantation
31
dinutuximab
29
Radiotherapy
29
Granulocyte Colony-Stimulating Factor
29
sargramostim
28
3-Iodobenzylguanidine
27
Granulocyte-Macrophage Colony-Stimulating Factor
25
Busulfan
22
Magnetic Resonance Spectroscopy
19
aldesleukin
18
Thiotepa
18
fludarabine
17
Interleukin-2
17
humanized 3F8 anti-GD2 monoclonal antibody
16
etoposide phosphate
16
Ifosfamide
15
naxitamab
14
fludarabine phosphate
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neuroblastoma
×
Interviews as Topic
×
Clear all
NCT02780128
2026-03-10
NEPENTHE
Children's Hospital of Philadelphia
Phase 1
Terminated
66 enrolled